Victor Ambros ’75, PhD ’79 and Gary Ruvkun share Nobel Prize in Physiology or Medicine
The scientists, who worked together as postdocs at MIT, are honored for their discovery of microRNA — a class of molecules that are critical for gene regulation.
Research quantifying “nociception” could help improve management of surgical pain
New statistical models based on physiological data from more than 100 surgeries provide objective, accurate measures of the body’s subconscious perception of pain.
3 Questions: Should we label AI systems like we do prescription drugs?
Researchers argue that in health care settings, “responsible use” labels could ensure AI systems are deployed appropriately.
A new way to reprogram immune cells and direct them toward anti-tumor immunity
MIT scientists’ discovery yields a potent immune response, could be used to develop a potential tumor vaccine.
3 Questions: What does innovation look like in the field of substance use disorder?
Hanna Adeyema and Carolina Haass-Koffler discuss the substance use disorder crisis and the future of innovation in the field.
Harnessing the power of placebo for pain relief
MIT researchers investigate the neural circuits that underlie placebos’ ability to relieve chronic and acute pain.
Pursuing the secrets of a stealthy parasite
By unraveling the genetic pathways that help Toxoplasma gondii persist in human cells, Sebastian Lourido hopes to find new ways to treat toxoplasmosis.
An implantable sensor could reverse opioid overdoses
The new device, which can be implanted under the skin, rapidly releases naloxone when an overdose is detected.
New method enables fast, accurate estimates of cardiovascular state to inform blood pressure management
A mathematical method, validated with experimental data, provides a fast, reliable, and minimally invasive way of determining how to treat critical blood pressure changes during surgery or intensive care.
Study reveals how an anesthesia drug induces unconsciousness
Propofol, a drug commonly used for general anesthesia, derails the brain’s normal balance between stability and excitability.
MIT engineers find a way to protect microbes from extreme conditions
By helping microbes withstand industrial processing, the method could make it easier to harness the benefits of microorganisms used as medicines and in agriculture.
MIT-Takeda Program wraps up with 16 publications, a patent, and nearly two dozen projects completed
The program focused on AI in health care, drawing on Takeda’s R&D experience in drug development and MIT’s deep expertise in AI.
MIT Faculty Founder Initiative announces three winners of entrepreneurship awards
Twelve finalists participated in initiative and 2023-24 MIT-Royalty Pharma Prize Competition, designed to support female biotech pioneers.
Study models how ketamine’s molecular action leads to its effects on the brain
New research addresses a gap in understanding how ketamine’s impact on individual neurons leads to pervasive and profound changes in brain network function.
“Rosetta Stone” of cell signaling could expedite precision cancer medicine
An atlas of human protein kinases enables scientists to map cell signaling pathways with unprecedented speed and detail.